FindTrial
Sign In

The study on clinical application of nanopore sequencing technology based on rolling circle amplification in detection of pathogenic microorganisms

The study on clinical application of nanopore sequencing technology based on rolling circle amplification in detection of pathogenic microorganisms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102173
Enrollment
Unknown
Registered
2025-05-09
Start date
2024-06-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infectious diseases

Interventions

Group of blood:none
Group of Bronchoalveolar lavage fluid:none
Group of Pleural effusion:none

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The rest samples of patients hospitalized for infectious diseases were sent to the laboratory for mNGS

Exclusion criteria

Exclusion criteria: There are obvious contamination samples

Design outcomes

Primary

MeasureTime frame
Accuracy: At least 238 out of 250 specimens are accurately detected (Accuracy > 95%);—

Secondary

MeasureTime frame
Sensitivity: At least 95% of the positive specimens are detected (Sensitivity rate > 95%);Specificity: The proportion of specimens that are truly negative and tested as negative. (Specificity rate> 95%);—

Countries

China

Contacts

Public ContactHongtao Xu

Beijing Hospital

taotao200703@sina.com+86 150 1059 4850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026